|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang C, Yuan W, Lai C, Zhong S, Yang C, Wang R, Mao L and Chen Z and Chen Z: EphA2-to-YAP pathway drives gastric cancer growth and therapy resistance. Int J Cancer. 146:1937–1949. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Z, Ran H, Wang Z, Zhou S and Wang Y: Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect. Int J Nanomedicine. 14:7627–7642. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu Z, Yu S, Ye S, Shen Z, Gao L, Han Z, Zhang P, Luo F, Chen S and Kang M: Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma. J Proteomics. 211:1035572020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang PB, Chen Y, Ding GR, Du HW and Fan HY: Keratin 18 induces proliferation, migration, and invasion in gastric cancer via the MAPK signalling pathway. Clin Exp Pharmacol Physiol. 48:147–156. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen B, Xu X, Lin DD, Chen X, Xu YT, Liu X and Dong WG: KRT18 modulates alternative splicing of genes involved in proliferation and apoptosis processes in both gastric cancer cells and clinical samples. Front Genet. 12:6354292021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Birkenkamp-Demtroder K, Hahn SA, Mansilla F, Thorsen K, Maghnouj A, Christensen R, Øster B and Ørntoft TF: Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells. PLoS One. 8:e735932013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim D, Brocker CN, Takahashi S, Yagai T, Kim T, Xie G, Wang H, Qu A and Gonzalez FJ: Keratin 23 is a peroxisome proliferator-activated receptor alpha-dependent, MYC-amplified oncogene that promotes hepatocyte proliferation. Hepatology. 70:154–167. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ren M, Gao Y, Chen Q, Zhao H, Zhao X and Yue W: The overexpression of keratin 23 promotes migration of ovarian cancer via epithelial-mesenchymal transition. Biomed Res Int. 2020:82187352020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Florido J, Martinez-Ruiz L, Rodriguez-Santana C, López-Rodríguez A, Hidalgo-Gutiérrez A, Cottet-Rousselle C, Lamarche F, Schlattner U, Guerra-Librero A, Aranda-Martínez P, et al: Melatonin drives apoptosis in head and neck cancer by increasing mitochondrial ROS generated via reverse electron transport. J Pineal Res. 73:e128242022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hsiao SY, Tang CH, Chen PC, Lin TH and Chao CC: Melatonin inhibits EMT in bladder cancer by targeting autophagy. Molecules. 27:86492022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hasan M, Marzouk MA, Adhikari S, Wright TD, Miller BP, Matossian MD, Elliott S, Wright M, Alzoubi M, Collins-Burow BM, et al: Pharmacological, mechanistic, and pharmacokinetic assessment of novel melatonin-tamoxifen drug conjugates as breast cancer drugs. Mol Pharmacol. 96:272–296. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hao J, Fan W, Li Y, Tang R, Tian C, Yang Q, Zhu T, Diao C, Hu S, Chen M, et al: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits. J Exp Clin Cancer Res. 38:482019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Q, Sun Z, Du L, Xu C, Wang Y, Yang B, He N, Wang J, Ji K, Liu Y and Liu Q: Melatonin Sensitizes human colorectal cancer cells to gamma-ray ionizing radiation in vitro and in vivo. Int J Mol Sci. 19:39742018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
JG DEA, Serra LSM, Lauand L, Kuckelhaus SAS and Sampaio ALL: Protective effect of melatonin on cisplatin-induced ototoxicity in rats. Anticancer Res. 39:2453–2458. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Palmer ACS, Zortea M, Souza A, Santos V, Biazús JV, Torres ILS, Fregni F and Caumo W: Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial. PLoS One. 15:e02313792020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song J, Ma SJ, Luo JH, Zhang H, Wang RX, Liu H, Li L, Zhang ZG and Zhou RX: Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway. Oncol Rep. 39:1975–1983. 2018.PubMed/NCBI
|
|
18
|
Wang RX, Liu H, Xu L, Zhang H and Zhou RX: Involvement of nuclear receptor RZR/RORgamma in melatonin-induced HIF-1alpha inactivation in SGC-7901 human gastric cancer cells. Oncol Rep. 34:2541–2546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ao L, Yan H, Zheng T, Wang H, Tong M, Guan Q, Li X, Cai H, Li M and Guo Z: Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments. Sci Rep. 5:118952015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B. 57:289–300. 1995.
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ao L, Li L, Sun H, Chen H, Li Y, Huang H, Wang X, Guo Z and Zhou R: Transcriptomic analysis on the effects of melatonin in gastrointestinal carcinomas. BMC Gastroenterol. 20:2332020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bubenik GA: Thirty four years since the discovery of gastrointestinal melatonin. J Physiol Pharmacol. 59 (Suppl 2):S33–S51. 2008.
|
|
24
|
Asghari MH, Moloudizargari M, Ghobadi E, Fallah M and Abdollahi M: Melatonin as a multifunctional anti-cancer molecule: Implications in gastric cancer. Life Sci. 185:38–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bubenik GA: Gastrointestinal melatonin: Localization, function, and clinical relevance. Dig Dis Sci. 47:2336–2348. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jaworek J, Brzozowski T and Konturek SJ: Melatonin as an organoprotector in the stomach and the pancreas. J Pineal Res. 38:73–83. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iesanu MI, Zahiu CDM, Dogaru IA, Chitimus DM, Pircalabioru GG, Voiculescu SE, Isac S, Galos F, Pavel B, O'Mahony SM and Zagrean AM: Melatonin-microbiome two-sided interaction in dysbiosis-associated conditions. Antioxidants (Basel). 11:22442022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo J, Song J, Zhang H, Zhang F, Liu H, Li L, Zhang Z, Chen L, Zhang M, Lin D, et al: Melatonin mediated Foxp3-downregulation decreases cytokines production via the TLR2 and TLR4 pathways in H. pylori infected mice. Int Immunopharmacol. 64:116–122. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Choudhary P, Roy T, Chatterjee A, Mishra VK, Pant S and Swarnakar S: Melatonin rescues swim stress induced gastric ulceration by inhibiting matrix metalloproteinase-3 via down-regulation of inflammatory signaling cascade. Life Sci. 297:1204262022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen KH, Zeng BY, Zeng BS, Sun CK, Cheng YS, Su KP, Wu YC, Chen TY, Lin PY, Liang CS, et al: The efficacy of exogenous melatonin supplement in ameliorating irritable bowel syndrome severity: A meta-analysis of randomized controlled trials. J Formos Med Assoc. 122:276–285. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kvetnoi IM and Levin IM: Daily excretion of melatonin in patients with cancer of the stomach and large intestine. Vopr Onkol. 33:29–32. 1987.PubMed/NCBI
|
|
32
|
Colombo F, Iannotta F, Fachinetti A, Giuliani F, Cornaggia M, Finzi G, Mantero G, Fraschini F, Malesci A, Bersani M, et al: Changes in hormonal and biochemical parameters in gastric adenocarcinoma. Minerva Endocrinol. 16:127–139. 1991.(In Italian). PubMed/NCBI
|
|
33
|
Lv JW, Zheng ZQ, Wang ZX, Zhou GQ, Chen L, Mao YP, Lin AH, Reiter RJ, Ma J, Chen YP and Sun Y: Pan-cancer genomic analyses reveal prognostic and immunogenic features of the tumor melatonergic microenvironment across 14 solid cancer types. J Pineal Res. 66:e125572019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Song J, Li Y, Lin C, Chen Y, Zhang X and Yu H: Melatonin inhibited the progression of gastric cancer induced by Bisphenol S via regulating the estrogen receptor 1. Ecotoxicol Environ Saf. 259:1150542023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang K, Cai R, Fei S, Chen X, Feng S, Zhang L, Liu H, Zhang Z, Song J and Zhou R: Melatonin enhances anti-tumor immunity by targeting macrophages PD-L1 via exosomes derived from gastric cancer cells. Mol Cell Endocrinol. 568–569. 1119172023.
|
|
36
|
Shi X, Li H, Dan Z, Shu C, Zhu R, Yang Q, Wang Y and Zhu H: Melatonin potentiates sensitivity to 5-fluorouracil in gastric cancer cells by upregulating autophagy and downregulating myosin light-chain kinase. J Cancer. 14:2608–2618. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cheng L, Li S, He K, Kang Y, Li T, Li C, Zhang Y, Zhang W and Huang Y: Melatonin regulates cancer migration and stemness and enhances the anti-tumour effect of cisplatin. J Cell Mol Med. 27:2215–2227. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lissoni P, Barni S, Mandala M, Ardizzoia A, Paolorossi F, Vaghi M, Longarini R, Malugani F and Tancini G: Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer. 35:1688–1692. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li Z, Shi C, Zheng J, Guo Y, Fan T, Zhao H, Jian D, Cheng X, Tang H and Ma J: Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma. BMC Microbiol. 21:3012021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Marrero-Rodríguez D, Taniguchi-Ponciano K, Subramaniam M, Hawse JR, Pitel KS, Arreola-De la Cruz H, Huerta-Padilla V, Ponce-Navarrete G, Figueroa-Corona MDP, Gomez-Virgilio L, et al: Krüppel-Like Factor 10 participates in cervical cancer immunoediting through transcriptional regulation of Pregnancy-Specific Beta-1 Glycoproteins. Sci Rep. 8:94452018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gu L, Feng C, Li M, Hong Z, Di W and Qiu L: Exosomal NOX1 promotes tumor-associated macrophage M2 polarization-mediated cancer progression by stimulating ROS production in cervical cancer: A preliminary study. Eur J Med Res. 28:3232023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Y, Han S, Wu B, Zhong C, Shi Y, Lv C, Fu L, Zhang Y, Lang Q, Liang Z, et al: CXCL11 correlates with immune infiltration and impacts patient immunotherapy efficacy: A pan-cancer analysis. Front Immunol. 13:9512472022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wedegaertner H, Pan WA, Gonzalez CC, Gonzalez DJ and Trejo J: The alpha-arrestin ARRDC3 is an emerging multifunctional adaptor protein in cancer. Antioxid Redox Signal. 36:1066–1079. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li JP, Zhang XM, Liu BC, Ren SG, Zhao XH and Liu YJ: Comprehensive analysis of the PTPN13 expression and its clinical implication in breast cancer. Neoplasma. 70:188–198. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shan Z, Li Y, Yu S, Wu J, Zhang C, Ma Y, Zhuang G, Wang J, Gao Z and Liu D: CTCF regulates the FoxO signaling pathway to affect the progression of prostate cancer. J Cell Mol Med. 23:3130–3139. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim J, Hu Z, Cai L, Li K, Choi E, Faubert B, Bezwada D, Rodriguez-Canales J, Villalobos P, Lin YF, et al: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells. Nature. 546:168–172. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhou Y, Zhou X, Huang X, Hong T, Zhang K, Qi W, Guo M and Nie S: Lysosome-mediated cytotoxic autophagy contributes to tea polysaccharide-induced colon cancer cell death via mTOR-TFEB signaling. J Agric Food Chem. 69:686–697. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bowling EA, Wang JH, Gong F, Wu W, Neill NJ, Kim IS, Tyagi S, Orellana M, Kurley SJ, Dominguez-Vidaña R, et al: Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. 184:384–403.e21. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tsai FJ, Lai MT, Cheng J, Chao SC, Korla PK, Chen HJ, Lin CM, Tsai MH, Hua CH, Jan CI, et al: Novel K6-K14 keratin fusion enhances cancer stemness and aggressiveness in oral squamous cell carcinoma. Oncogene. 38:5113–5126. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Perone Y, Farrugia AJ, Rodriguez-Meira A, Győrffy B, Ion C, Uggetti A, Chronopoulos A, Marrazzo P, Faronato M, Shousha S, et al: SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERalpha breast cancer. Nat Commun. 10:21152019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yao S, Huang HY, Han X, Ye Y, Qin Z, Zhao G, Li F, Hu G, Hu L and Ji H: Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation. Oncogene. 38:6354–6369. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hrudka J, Fiserova H, Jelinkova K, Matej R and Waldauf P: Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma. Sci Rep. 11:178632021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
An Q, Liu T, Wang MY, Yang YJ, Zhang ZD, Liu ZJ and Yang B: KRT7 promotes epithelialmesenchymal transition in ovarian cancer via the TGFβ/Smad2/3 signaling pathway. Oncol Rep. 45:481–492. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Eckstein M, Wirtz RM, Gross-Weege M, Breyer J, Otto W, Stoehr R, Sikic D, Keck B, Eidt S, Burger M, et al: mRNA-expression of KRT5 and KRT20 defines distinct prognostic subgroups of muscle-invasive urothelial bladder cancer correlating with histological variants. Int J Mol Sci. 19:33962018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang K, Liang Y, Zhang W, Zeng N, Tang S and Tian R: KRT81 knockdown inhibits malignant progression of melanoma through regulating interleukin-8. DNA Cell Biol. 40:1290–1297. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang N, Zhang R, Zou K, Yu W, Guo W, Gao Y, Li J, Li M, Tai Y, Huang W, et al: Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth. Cell Death Dis. 8:e29612017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Min L, Zhao Y, Zhu S, Qiu X, Cheng R, Xing J, Shao L, Guo S and Zhang S: Integrated analysis identifies molecular signatures and specific prognostic factors for different gastric cancer subtypes. Transl Oncol. 10:99–107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jiang QG, Xiong CF and Lv YX: Kin17 facilitates thyroid cancer cell proliferation, migration, and invasion by activating p38 MAPK signaling pathway. Mol Cell Biochem. 476:727–739. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhong C, Chen C, Yao F and Fang W: ZNF251 promotes the progression of lung cancer by activating ERK signaling. Cancer Sci. 111:3236–3244. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Xiong L, Guo W, Yang Y, Gao D, Wang J, Qu Y and Zhang Y: Tectoridin inhibits the progression of colon cancer through downregulating PKC/p38 MAPK pathway. Mol Cell Biochem. 476:2729–2738. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Niu M, Zhang B, Li L, Su Z, Pu W, Zhao C, Wei L, Lian P, Lu R, Wang R, et al: Targeting HSP90 inhibits proliferation and induces apoptosis through AKT1/ERK pathway in lung cancer. Front Pharmacol. 12:7241922021. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Alvarez-Artime A, Cernuda-Cernuda R, Francisco Artime N, Cepas V, Gonzalez-Menendez P, Fernadez-Vega S, Quiros-Gonzalez I, Sainz RM and Mayo JC: Melatonin-induced cytoskeleton reorganization leads to inhibition of melanoma cancer cell proliferation. Int J Mol Sci. 21:5482020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang SW, Tai HC, Tang CH, Lin LW, Lin TH, Chang AC, Chen PC, Chen YH, Wang PC, Lai YW and Chen SS: Melatonin impedes prostate cancer metastasis by suppressing MMP-13 expression. J Cell Physiol. 236:3979–3990. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chao CC, Chen PC, Chiou PC, Hsu CJ, Liu PI, Yang YC, Reiter RJ, Yang SF and Tang CH: Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to Twist. Clin Sci (Lond). 133:709–722. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Proietti S, Catizone A, Masiello MG, Dinicola S, Fabrizi G, Minini M, Ricci G, Verna R, Reiter RJ, Cucina A and Bizzarri M: Increase in motility and invasiveness of MCF7 cancer cells induced by nicotine is abolished by melatonin through inhibition of ERK phosphorylation. J Pineal Res. 64:e124672018. View Article : Google Scholar : PubMed/NCBI
|
